PAUL W. CLOUGH, M.D.
Autoimmune hemolytic anemia is a designation commonly applied to a group of cases of acquired hemolytic anemia in which neither an inherited abnormality of the cells nor an extrinsic cause, such as an infection or drug intoxication, can be found. This syndrome may appear in previously normal individuals, the "idiopathic group." An identical form may be found in a few subjects with certain serious underlying diseases (the "symptomatic" group), most often in lymphatic leukemia or lymphoma, more rarely in other malignant neoplasms, disseminated lupus, periarteritis nodosa, cirrhosis.
Cases of this acquired type have been recognized for 50 years, since the
CLOUGH PW. RECENT OBSERVATIONS REGARDING THE PATHOGENESIS AND TREATMENT OF ACQUIRED AUTOIMMUNE HEMOLYTIC ANEMIA. Ann Intern Med. ;46:819–826. doi: 10.7326/0003-4819-46-4-819
Download citation file:
Published: Ann Intern Med. 1957;46(4):819-826.
Hematology/Oncology, Red Cell Disorders.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use